These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 8469228

  • 1. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
    Bergeron C, Le Moine P, Le Prise-Fleury E, Jouan H, Tass P, Darcel F, Chatel M, Edan C, Patte C, Faivre J.
    Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
    [Abstract] [Full Text] [Related]

  • 2. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, Herrmann R, Greil R, Anselmo AP, Diehl V.
    J Clin Oncol; 2002 Jan 15; 20(2):476-84. PubMed ID: 11786577
    [Abstract] [Full Text] [Related]

  • 3. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL, Barbieri E, Visani G, Gherlinzoni F, Perini F, Neri S, Bendandi M, Ammendolia I, Salvucci M, Babini L.
    Haematologica; 1994 Jan 15; 79(6):508-12. PubMed ID: 7534744
    [Abstract] [Full Text] [Related]

  • 4. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A, Pita Ramírez L, Hurtado Monroy R, Angeles-Angeles A.
    Rev Invest Clin; 1992 Jan 15; 44(3):393-8. PubMed ID: 1283228
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. European experience with ifosfamide in lymphomas.
    von Kalle AK, Schaadt M, Diehl V.
    Semin Oncol; 1989 Feb 01; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [Abstract] [Full Text] [Related]

  • 9. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM, Brody J, Kaplan MH, Susin M, Koduru P, Goh JC.
    Leuk Lymphoma; 1993 Mar 01; 9(4-5):393-8. PubMed ID: 7688628
    [Abstract] [Full Text] [Related]

  • 10. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
    Borchmann P, Haverkamp H, Lohri A, Mey U, Kreissl S, Greil R, Markova J, Feuring-Buske M, Meissner J, Dührsen U, Ostermann H, Keller U, Maschmeyer G, Kuhnert G, Dietlein M, Kobe C, Eich H, Baues C, Stein H, Fuchs M, Diehl V, Engert A.
    Lancet Oncol; 2017 Apr 01; 18(4):454-463. PubMed ID: 28236583
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
    Dodwell DJ, de Campos ES, Radford JA.
    Drugs; 1992 Jul 01; 44(1):1-8. PubMed ID: 1379906
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 15. Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
    Oguchi M, Izuno I, Takei K, Shikama N, Sasaki S, Gomi K, Sone S.
    Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):87-92. PubMed ID: 9054881
    [Abstract] [Full Text] [Related]

  • 16. [Chylothorax resulting from malignant non Hodgkin's lymphoma].
    Ohyama S, Bando K, Hasegawa Y, Taniguti M, Shirayma H.
    Nihon Kokyuki Gakkai Zasshi; 1998 May 01; 36(5):473-7. PubMed ID: 9742867
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Eichenauer DA, Plütschow A, Kreissl S, Sökler M, Hellmuth JC, Meissner J, Mathas S, Topp MS, Behringer K, Klapper W, Kuhnert G, Dietlein M, Kobe C, Fuchs M, Diehl V, Engert A, Borchmann P.
    Lancet Oncol; 2017 Dec 01; 18(12):1680-1687. PubMed ID: 29133014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
    Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB.
    N Engl J Med; 1997 Oct 30; 337(18):1259-66. PubMed ID: 9345074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.